💊 Can chronic insomnia be treated long-term? In-depth analysis of the safety of Dali Lesheng after 12 months of use📈
Share
🌙 The challenges of treating chronic insomnia and the necessity of long-term medication 😴
Chronic insomnia refers to It occurs at least 3 times a week and continues More than 3 months Sleep disorders affect approximately [number missing] people worldwide. 10-15% Adults. These patients face a core dilemma: long-term insomnia damages their health, but they worry about the safety risks of long-term medication.
Daridorexant As a new generation A dual orexin receptor antagonist has had its long-term safety systematically evaluated in a pivotal clinical study over 12 months, providing a new long-term management option for patients with chronic insomnia. 🛌
📊 Core Research: SUNRISE-2 Long-Term Safety Data ✅
A 12-month period Double-blind, randomized, placebo-controlled study (SUNRISE-2) evaluated the long-term efficacy and safety of daliresen, and the results were published in JAMA Psychiatry.
|
Evaluation indicators |
Daliresen 50mg group 🆚 |
placebo group |
Clinical significance 📝 |
|
12-month sustained effectiveness |
Sleep onset time continues to shorten ⬇️, sleep efficiency continues to improve ⬆️ |
The effect decreases with the course of treatment. |
No tolerance to the treatment , long-term stability 🎯 |
|
Improved daytime function |
Significant improvement in the Daytime Sleepiness Scale (ESS) score 🌅 |
No significant improvement |
Improve nighttime and daytime symptoms and enhance quality of life ☀️ |
|
Rebound insomnia after discontinuation of medication |
The incidence rate is extremely low, comparable to that of a placebo. |
none |
Low withdrawal risk , smooth discontinuation process 🛑 |
|
Drug dependence tendency |
No obvious cravings or abuse were observed. |
none |
Extremely low risk of addiction , high safety🛡️ |
🛡️ Detailed analysis of the safety of long-term medication
1️⃣ Neurological safety: impact on next-day function and cognition 🧠
● Daytime sleepiness : In long-term studies, the Daliresen group and the placebo group showed differences in daytime sleepiness and alertness tests (such as performance on driving simulators). No significant difference ✅.
● Cognitive function : No negative effects on cognitive functions such as memory and attention were observed after 12 months of medication.
● Balance and fall risk : Subgroup analysis of older adults showed no significant increase in fall risk, which is related to the drug's mechanism of action. Highly selective Regarding 👴🏻👵🏻.
2️⃣ Adverse reaction profile and tolerability ⚠️
● Common adverse reactions : mainly Mild to moderate , the most common type is Headache (approximately 7%) 🤕 and Drowsiness (approximately 6%) 😪, often appears in the early stages of treatment and lessens over time.
● No serious organ toxicity : During the study period No findings Clinically significant abnormalities in liver function, kidney function, or electrocardiogram related to medication ❤️.
● Good tolerance : Up to 96% Patients completed 12 months of treatment with a low discontinuation rate due to adverse reactions 👍.
3️⃣ Long-term safety of special populations 👥
● Elderly (≥65 years old): Recommended dose is 25mg (Half of the usual adult dose of 50mg), with good long-term safety.
● Patients with hepatic or renal insufficiency : No dosage adjustment is required for patients with mild to moderate hepatic or renal insufficiency, but long-term use under close monitoring by a physician is necessary.
4️⃣ Risk of dependence and withdrawal syndrome 🔓
Because Daly Reisen does not act on traditional GABA systems, it leads to The potential for dependence and abuse is extremely low . No typical withdrawal syndrome was observed after long-term treatment. Insomnia may rebound severely, but the process of discontinuing medication is usually smooth.
⚖️ Benefits and Risks of Long-Term Medication Use
For patients with chronic insomnia, the decision to use medication long-term requires careful consideration:
● ✅ Long-term benefits : Breaks the vicious cycle of "insomnia-anxiety-insomnia", stabilizes biological rhythms, improves daytime function and quality of life, and prevents mood disorders and cardiovascular risks caused by insomnia.
● ⚠️ Precautions : The necessity of treatment needs to be reassessed regularly (e.g., every 3-6 months); it needs to be combined with non-pharmacological interventions (e.g., CBT-I); individual responses to the medication need to be monitored.
💡 Long-term medication recommendations for patients with chronic insomnia 🎯
1. Start with diagnosis : Get a clear diagnosis of chronic insomnia from a professional doctor and rule out other treatable causes.
2. Individualized start : Start with the recommended dose and observe initial response and tolerability.
3. Regular follow-up evaluations : Work with your doctor to develop a follow-up appointment plan and assess whether medication needs to be continued 📅.
4. Combination therapy : Treating drug therapy as a tool, learning and practicing it simultaneously. Cognitive Behavioral Therapy (CBT-I) Non-drug techniques can lay the foundation for future reduction or discontinuation of medication 🧘♂️.
5. Lifestyle Foundation : Maintain regular sleep schedules, create a dark and quiet sleep environment, and engage in moderate exercise during the day.
Managing chronic insomnia is a marathon, not a sprint. Dali Reson provides a reliable long-term support tool with its proven 12-month safety profile. 🏁
🏆 Asakusa Cosmetics provides you with
✔️ Authentic Dali Leisheng
✔️ Hospital prescription
✔️ Online doctor consultation
✔️ Pharmacist's Medication Instructions
✔️ Comprehensive after-sales tracking service
⚠️ Friendly reminder: This article is for reference only. Please consult your doctor for specific medication advice.
---------------------------------------------------------------------------------------------------
📞Welcome to scroll down to contact customer service, purchase online, and have it shipped directly to your door.